Psyence Biomedical Ltd.
13F holders, Q1 2024 (March 31)10holders
$1.12avg. 13F price*
At the end of Q1 2024, 10 institutions reported holding Psyence Biomedical Ltd. in their 13F filings. The largest holders were Cantor Fitzgerald, L. P. ($371K), AdvisorShares Investments LLC ($309K) and Two Sigma Securities, LLC ($64K).
- Company
- Psyence Biomedical Ltd.
- CUSIP
- 74449F100
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $831K |
| Exits | 0 | $0 |
Ownership 10 holders
| Cantor Fitzgerald, L. P. | 0.09% | New | 337,000 | $371K |
| AdvisorShares Investments LLC | 0.06% | New | 271,336 | $309K |
| Two Sigma Securities, LLC | 0.00% | New | 55,776 | $64K |
| Virtu Financial LLC | 0.00% | New | 26,419 | $30K |
| Cowen and Company, LLC | 0.00% | New | 25,000 | $29K |
| HRT Financial LP | 0.00% | New | 12,611 | $14K |
| Geode Capital Management, LLC | 0.00% | New | 10,488 | $12K |
| UBS Group AG | 0.00% | New | 2,364 | $3K |
| Headlands Technologies LLC | 0.00% | New | 96 | $109 |
| JPMorgan Chase & Co. | 0.00% | New | 2 | $2 |
"% of holder's portfolio" is PSYENCE BIOMEDICAL LTD's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.